This resource helps companies navigate the steady stream of policy shifts under the Biden-Harris administration, decipher the intersection of global laws and dealmaking opportunities for multinational companies, and interpret the latest developments in climate, privacy, and social issues.
US President Joe Biden and Vice President Kamala Harris have set an aggressive pace of executive orders, regulatory and legislative changes, and proposed rulemaking to address the ongoing COVID-19 pandemic, a recovering economy, calls for racial justice, existing immigration and foreign policy, and a renewed focus on climate change, among other priorities.
Climate change is no longer solely the concern of scientists. Governments, businesses, and individuals are making a concerted effort to change their patterns to protect the environment.
As dealmaking surges in most parts of the world, investors and companies are jockeying for new market positions. The dramatically different landscape of how people work, where they travel, and what they buy in a global economy still recovering from a major public health crisis has brought both opportunity and challenge. Assets for individual and company consumers may be tough to come by as international supply chains and trade restrictions remain in flux. Morgan Lewis lawyers from around the globe address these issues by offering insight into merger and acquisition trends, international trade and sanctions, and the global supply network.
The role of technology and data continues to expand in both corporate operations and day-to-day interactions. Companies are at a critical crossroads of how to leverage this connectivity while protecting themselves from cyberattacks, data breaches, and an increasingly complicated regulatory environment. Morgan Lewis is closely tracking the explosion of data privacy laws and technological innovations to help major industries around the globe understand how these changes could affect their businesses.
As the world works toward a goal of delivering safe and effective COVID-19 vaccines, employers, healthcare providers, and many others are considering the potential implications for their industries and organizations.